With the analysis among 1,184 patents, we discovered top 429 key players by total patent application. DSM IP Assets BV, BASF AB, Asahi Kasei Medical Co., Ltd. are dominant in this area. They take 17.65% of the total patent filing.
Tokyo-to, Japan
Patent: 37
Shanghai Shi, China
Patent: 29
Osaka-fu, Japan
Patent: 22
Noord-Holland, Netherlands
Patent: 17
Vaud, Switzerland
Patent: 17
Kansas, United States
Patent: 15
No data, please try another search term
With the analysis among related 291 patents applied in the last 5 years. We discover 173 most active companies in this area. The fast-growing DSM IP Assets BV, Shanghai Austrian Doctor Biomedical Technology Co., Ltd., BASF AB take 17.53% of patent filing during this period.
Shanghai Shi, China
Patent: 11
Zhejiang Sheng, China
Patent: 4
PARAPHARM DEVELOPMENT LIMITED
Chiba-ken, Japan
Patent: 4
Jiangsu Sheng, China
Patent: 3
With the analysis among related 291 patents in last 5 years, we discover 152 new entrants. PARAPHARM DEVELOPMENT LIMITED, Chiba University, TOSHIBA Corp. are the most active new entrants in this area.
PARAPHARM DEVELOPMENT LIMITED
Chiba-ken, Japan
Patent: 4
Jiangsu Sheng, China
Patent: 3
Beijing Shi, China
Patent: 3
Hubei Zhenao Pharmaceutical Research Institute Co., Ltd.
Hubei Sheng, China
Patent: 3
Guangdong Sheng, China
Patent: 3
Changsha King-eagle Med Technology Co., Ltd.
Hunan Sheng, China
Patent: 2
Shaanxi Sheng, China
Patent: 2
Suzhou Yikun Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 2
With the analysis among 167 patents, we discovered top 39 universities and scientific research institutions by total patent application. Hokkaido University, Chiba University, Jiangnan University are dominant in this area. They take 25.75% of the total patent filing.
Hokkaido, Japan
Patent: 11
Chiba-ken, Japan
Patent: 4
Jiangsu Sheng, China
Patent: 4
Guangdong Sheng, China
Patent: 3
Shaanxi Sheng, China
Patent: 2
Fukuoka-ken, Japan
Patent: 2
Jiangxi Sheng, China
Patent: 2
Zhejiang Sheng, China
Patent: 2